Bemotrizinol, recently approved as a new active ingredient in sunscreens, is the first new ingredient for OTC sunscreen ...

Pregnancy may not be a risk factor for invasive melanoma or melanoma in situ, though women of reproductive age may be at an increased risk.

Whereas both dosing regimens of abrocitinib were effective among patients with atopic dermatitis, continuous treatment with abrocitinib 200 mg was associated with greater efficacy rates than variable ...

The addition of microneedling to topical minoxidil for the treatment of women with androgenetic alopecia provides no ...

The FDA has assigned a Prescription Drug User Fee Act (PDUFA) target action date of February 23, 2027. The Food and Drug Administration (FDA) has accepted for review the supplemental New Drug ...

Researchers studied the relationship between dermatologist density and the proportion of late-stage melanoma diagnoses.

Researchers studied the effectiveness of a food supplement on improving hair density among patients with non-illness-related hair thinning and loss.

Among patients with psoriasis or atopic dermatitis who had phenotype switching, Janus kinase inhibitors were the most commonly used treatments for therapy modification. Treatment-associated phenotype ...

Rheumatoid factor may be associated with more significant disease burden and less response to treatment in patients with PsA.

States that adopted cost-growth benchmark programs saw a 2% reduction in per capita total medical expenditure growth.

The FDA approval of marketing for new nicotine pouches has sparked widespread criticism that is backed by recent survey results, which revealed that 1.7% of middle and high school students now use ...

No significant difference in the risk for serious infections in patients with psoriasis was noted among most systemic ...